Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.

Dutcher JP, Logan T, Gordon M, Sosman J, Weiss G, Margolin K, Plasse T, Mier J, Lotze M, Clark J, Atkins M
Clin Cancer Res. 2000 6 (9): 3442-50

PMID: 10999727

MeSH Terms (20)

Adult Aged Antineoplastic Combined Chemotherapy Protocols Carcinoma, Renal Cell Combined Modality Therapy Dose-Response Relationship, Drug Drug Administration Schedule Female Fluorouracil Humans Interferon-alpha Interferon alpha-2 Interleukin-2 Kidney Neoplasms Male Middle Aged Outpatients Quality of Life Recombinant Proteins Reproducibility of Results

Connections (1)

This publication is referenced by other Labnodes entities:

Links